| (INR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 22.70B | — |
| Operating expense | — | — |
| Net income | -693.90M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, PPLPHARMA.NS returned +10.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +24.1% |
| 1 year | +10.9% |
| All-time high | ₹268.75 (Nov 2024) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ₹1,000 in PPLPHARMA.NS would be worth today ›No. Piramal Pharma Limited has not paid a dividend in the past 12 months.
Piramal Pharma Limited is part of the Healthcare sector.
Piramal Pharma Limited has a market cap of 279.78B INR, based on the latest quote.
